Soleus Capital Master Fund, L.P. - 23 Apr 2025 SCHEDULE 13D/A Report for ESSA PHARMA, INC. Common Stock (EPIX)

Filing Manager
Soleus Capital Master Fund, L.P.
Reporting Manager
SOLEUS CAPITAL MASTER FUND, L.P.
Security
ESSA PHARMA, INC. Common Stock
Symbol
EPIX
Shares outstanding
44,353,451 shares
Disclosed Ownership
2,262,026 shares
Ownership
5.1%
Form type
SCHEDULE 13D/A
Filing time
23 Apr 2025, 21:45:31 UTC
Date of event
23 Apr 2025
Previous filing
15 Apr 2025
Next filing
21 Jul 2025
SEC
View on sec.gov

Quoteable Key Fact

"Soleus Capital Master Fund, L.P. disclosed 5.1% ownership in ESSA PHARMA, INC. Common Stock (EPIX) on 23 Apr 2025."

Quick Takeaways

  • Soleus Capital Master Fund, L.P. filed SCHEDULE 13D/A for ESSA PHARMA, INC. Common Stock (EPIX).
  • Disclosed ownership: 5.1%.
  • Date of event: 23 Apr 2025.

What Changed

  • Previous schedule filing date: 15 Apr 2025.
  • Current filing was accepted on 23 Apr 2025, 21:45.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
SOLEUS CAPITAL MASTER FUND, L.P. 5.1% 2,262,026 0 2,262,026 /s/ Guy Levy Soleus Capital, LLC, Its General Partner 0001812275
SOLEUS CAPITAL, LLC 5.1% 2,262,026 0 2,262,026 /s/ Guy Levy Soleus Capital Group, LLC, Its Managing Member
SOLEUS CAPITAL GROUP, LLC 5.1% 2,262,026 0 2,262,026 /s/ Guy Levy Guy Levy, Managing Member
SOLEUS CAPITAL MANAGEMENT, L.P. 5.1% 2,262,026 0 2,262,026 /s/ Guy Levy Soleus GP, LLC, Its General Partner
SOLEUS GP, LLC 5.1% 2,262,026 0 2,262,026 /s/ Guy Levy Guy Levy, Managing Member
GUY LEVY 5.1% 2,262,026 0 2,262,026 /s/ Guy Levy Guy Levy